For most preexisting comorbidities such as hypertension, cardiovascular diseases, or diabetes mellitus that increase the risk of severe COVID-19 [51], various studies have shown the progressive association of IFN insensitivity and chemokine/cytokine-mediated chronic inflammation and have been reviewed elsewhere [41,42,43,44]. The gene discussed is IFNA1; the disease is COVID-19.